Pharma Journalist - Page 842 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Boston Biomedical Announces Orphan Drug Designation by FDA for DSP-7888

AbbVie & Turnstone announces collaboration on Viral Immunotherapies in Oncology

Astellas Pharma and Seattle Genetics Initiate Pivotal Trial of Enfortumab Vedotin

FDA accepts Allergan’s new drug application for Ulipristal Acetate for Uterine Fibroids

FDA grants Breakthrough Therapy Designation to Ansun’s Experimental Drug DAS181

FDA grants Priority Review to Gilotrif for uncommon EGFR mutations in advanced NSCLC

EMA accepts Marketing application for Imfinzi to treat NSCLC patients

Parata Systems Enters Agreement with American Associated Pharmacies

Piramal Pharma Solutions Announces Large-scale Expansion of API Manufacturing Facilities

Merck Discontinues MK-3682B and MK-3682C Development Programs